Surf Air Mobility (SRFM) S-4 24 Oct 22 Registration of securities issued in business combination transactions Financial data

Document And Entity Information

Document And Entity Information	6 Months Ended
	Jun. 30, 2022
Document Information Line Items
Entity Registrant Name	SURF AIR MOBILITY INC.
Document Type	S-4
Amendment Flag	false
Entity Central Index Key	0001936224
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Incorporation, State or Country Code	DE

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
ASSETS
Cash	$ 61,865	$ 267,965	$ 515,524
Other receivable – related party			22,195
Other receivable	16	16
Prepaid expenses and other current assets	29,750	10,000	26,500
Total Current Assets	91,631	277,981	564,219
Marketable securities held in Trust Account	27,332,896	127,414,527	174,550,466
Total Assets	27,424,527	127,692,508	175,114,685
Current liabilities
Accounts payable and accrued expenses	414,689	624,663	163,910
Promissory note – related party	2,699,020	2,171,460
Redemption liability		31,596,178
Total Current Liabilities	3,113,709	34,392,301	296,130
Income tax payable			132,220
Warrant liabilities	423,937	1,054,856	3,865,313
Deferred tax liability			1,282
Total Liabilities	3,537,646	35,447,157	4,162,725
Commitments and Contingencies
Common stock subject to possible redemption	27,310,612	95,412,038	174,281,305
Stockholders’ Deficit
Preferred stock value
Common stock value	474	474	474
Accumulated deficit	(3,424,205)	(3,167,161)	(3,329,819)
Total Stockholders’ Deficit	(3,423,731)	(3,166,687)	(3,329,345)
Total Liabilities and Stockholders’ Deficit	$ 27,424,527	$ 127,692,508	$ 175,114,685

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parentheticals) - $ / shares	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Common stock subject to possible redemption	2,618,101	9,307,645	17,250,000
Common stock subject to possible redemption, shares at redemption value (in Dollars per share)	$ 10.43	$ 10.25
Preference stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Preference stock, shares authorized	1,000,000	1,000,000	1,000,000
Preference stock, shares issued
Preference stock, shares outstanding
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	50,000,000	50,000,000	50,000,000
Common stock, shares issued	4,737,500	4,737,500	4,737,500
Common stock, shares outstanding	4,737,500	4,737,500	4,737,500

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Operating and formation costs	$ 382,520	$ 234,792	$ 648,254	$ 477,766	$ 1,093,489	$ 619,292
Loss from operations	(382,520)	(234,792)	(648,254)	(477,766)	(1,093,489)	(619,292)
Other income (expense):
Change in fair value of warrant liability	922,688	(172,068)	630,919	975,057	2,810,457	(1,446,375)
Interest earned on marketable securities held in Trust Account	38,457	3,865	48,060	38,639	59,046	1,386,880
Unrealized gains on marketable securities held in Trust Account				15,769		(4,365)
Total other income (expense), net	961,145	(168,203)	678,979	1,029,465	2,869,503	(63,860)
Income (loss) before provision for income taxes	578,625	(402,995)	30,725	551,699	1,776,014	(683,152)
Provision for income taxes		(2,239)		(2,239)		(160,276)
Net income (loss)	$ 578,625	$ (405,234)	$ 30,725	$ 549,460	$ 1,776,014	$ (843,428)
Basic and diluted weighted average shares outstanding, Common stock (in Shares)	7,391,537	19,428,760	10,626,479	20,403,518	19,550,323	21,987,500
Basic and diluted net income (loss) per share, Common stock (in Dollars per share)	$ 0.08	$ (0.06)	$ 0	$ 0.08	$ 0.09	$ (0.04)

Condensed Statements of Opera_2

Condensed Statements of Operations (Unaudited) (Parentheticals) - $ / shares	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Basic and diluted weighted average shares outstanding, Common stock (in Shares)	7,391,537	19,428,760	10,626,479	20,403,518	19,550,323	21,987,500
Basic and diluted net income (loss) per share, Common stock (in Dollars per share) (in Dollars per share)	$ 0.08	$ (0.06)	$ 0	$ 0.08	$ 0.09	$ (0.04)

Condensed Statements of Changes

Condensed Statements of Changes in Stockholders’ Deficit (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2019	$ 474		$ (1,895,262)	$ (1,894,788)
Balance (in Shares) at Dec. 31, 2019	4,737,500
Remeasurement adjustment to amount subject to redemption			(591,129)	(591,129)
Net income (loss)			(843,428)	(843,428)
Balance at Dec. 31, 2020	$ 474		(3,329,819)	(3,329,345)
Balance (in Shares) at Dec. 31, 2020	4,737,500
Remeasurement adjustment to amount subject to redemption			(178,225)	(178,225)
Net income (loss)			954,694	954,694
Balance at Mar. 31, 2021	$ 474		(2,553,350)	(2,552,876)
Balance (in Shares) at Mar. 31, 2021	4,737,500
Balance at Dec. 31, 2020	$ 474		(3,329,819)	(3,329,345)
Balance (in Shares) at Dec. 31, 2020	4,737,500
Net income (loss)				549,460
Balance at Jun. 30, 2021	$ 474		(2,405,587)	(2,405,113)
Balance (in Shares) at Jun. 30, 2021	4,737,500
Balance at Dec. 31, 2020	$ 474		(3,329,819)	(3,329,345)
Balance (in Shares) at Dec. 31, 2020	4,737,500
Remeasurement adjustment to amount subject to redemption			(1,613,356)	(1,613,356)
Net income (loss)			1,776,014	1,776,014
Balance at Dec. 31, 2021	$ 474		(3,167,161)	(3,166,687)
Balance (in Shares) at Dec. 31, 2021	4,737,500
Balance at Mar. 31, 2021	$ 474		(2,553,350)	(2,552,876)
Balance (in Shares) at Mar. 31, 2021	4,737,500
Remeasurement adjustment to amount subject to redemption			552,997	552,997
Net income (loss)			(405,234)	(405,234)
Balance at Jun. 30, 2021	$ 474		(2,405,587)	(2,405,113)
Balance (in Shares) at Jun. 30, 2021	4,737,500
Balance at Dec. 31, 2021	$ 474		(3,167,161)	(3,166,687)
Balance (in Shares) at Dec. 31, 2021	4,737,500
Remeasurement adjustment to amount subject to redemption			259,247	259,247
Net income (loss)			(547,900)	(547,900)
Balance at Mar. 31, 2022	$ 474		(3,455,814)	(3,455,340)
Balance (in Shares) at Mar. 31, 2022	4,737,500
Balance at Dec. 31, 2021	$ 474		(3,167,161)	(3,166,687)
Balance (in Shares) at Dec. 31, 2021	4,737,500
Net income (loss)				30,725
Balance at Jun. 30, 2022	$ 474		(3,424,205)	(3,423,731)
Balance (in Shares) at Jun. 30, 2022	4,737,500
Balance at Mar. 31, 2022	$ 474		(3,455,814)	(3,455,340)
Balance (in Shares) at Mar. 31, 2022	4,737,500
Remeasurement adjustment to amount subject to redemption			(547,016)	(547,016)
Net income (loss)			578,625	578,625
Balance at Jun. 30, 2022	$ 474		$ (3,424,205)	$ (3,423,731)
Balance (in Shares) at Jun. 30, 2022	4,737,500

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Cash Flows from Operating Activities:
Net income (loss)	$ 30,725	$ 549,460	$ 1,776,014	$ (843,428)
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of warrant liability	(630,919)	(975,057)	(2,810,457)	1,446,375
Interest earned on marketable securities held in Trust Account	(48,060)	(38,639)	(59,046)	(1,386,880)
Unrealized gain on marketable securities held in Trust Account		(15,769)		4,365
Deferred tax liability			(1,282)	(6,400)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(19,750)	(12,500)	16,500	66,324
Prepaid income taxes				34,456
Other receivable		22,179	22,179	(22,195)
Accounts payable and accrued expenses	(209,974)	168,403	460,753	15,071
Income tax payable		(132,220)	(132,220)	132,220
Net cash used in operating activities	(877,978)	(434,143)	(727,559)	(560,092)
Cash Flows from Investing Activities:
Cash withdrawn from Trust Account for working capital purposes	250,000			250,000
Cash withdrawn from Trust Account to pay franchise and income taxes	421,878	480,000	480,000	406,313
Cash withdrawn from Trust Account to redeeming stockholders	99,985,373	25,827,849	48,886,445
Extension contribution	(527,560)		(2,171,460)
Net cash provided by investing activities	100,129,691	26,307,849	47,194,985	656,313
Cash Flows from Financing Activities:
Proceeds from promissory note – related party	527,560		2,171,460
Redemption of common stock	(99,985,373)	(25,827,849)	(48,886,445)
Net cash used in financing activities	(99,457,813)	(25,827,849)	(46,714,985)
Net Change in Cash	(206,100)	45,857	(247,559)	96,221
Cash – Beginning	267,965	515,524	515,524	419,303
Cash – Ending	61,865	561,381	267,965	515,524
Non-cash investing and financing activities:
Remeasurement adjustment to amount subject to redemption	$ 287,769	$ (374,772)	$ 1,613,356	$ 591,129

Description of Organization and

Description of Organization and Business Operations	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Tuscan Holdings Corp. II (the “Company”) is a blank check company incorporated in Delaware on March 5, 2019. The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of June 30, 2022, the Company had not commenced any operations. All activity through June 30, 2022 relates to the Company’s formation, its initial public offering (“Initial Public Offering”), which is described below, and, after the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non -operating The registration statement for the Company’s Initial Public Offering was declared effective on July 11, 2019. On July 16, 2019, the Company consummated the Initial Public Offering of 15,000,000 units (the “Units” and, with respect to the shares of common stock included in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $150,000,000. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 215,000 units (the “Private Units”) at a price of $10.00 per Private Unit and the sale of 2,150,000 warrants (the “Private Warrants” and, together with the Private Units, the “Private Securities”) at a price of $1.00 per Private Warrant in a private placement to Tuscan Holdings Acquisition II LLC (the “Sponsor”) and EarlyBirdCapital, Inc. (“EarlyBirdCapital”) and its designee, generating gross proceeds of $4,300,000. Following the closing of the Initial Public Offering on July 16, 2019, an amount of $150,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Securities was placed in a trust account (the “Trust Account”) which were invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open -ended -7 On July 18, 2019, the underwriters exercised their over -allotment -allotment The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Securities, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post -Business The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account ($10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income tax obligations and up to $250,000 per 12 -month The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Company’s Sponsor and EarlyBirdCapital (and its designee) have agreed to vote their Founder Shares, Representative Shares, Private Shares and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination and not to convert any shares in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against the proposed Business Combination. The Sponsor and EarlyBirdCapital (and its designee) have agreed (a) to waive their redemption rights with respect to their Founder Shares, Private Shares and Public Shares held by them in connection with the completion of a Business Combination, (b) to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares, Representative Shares and Private Shares if the Company fails to consummate a Business Combination, and (c) not to propose an amendment to the Amended and Restated Certificate of Incorporation that would affect a public stockholders’ ability to convert or sell their shares to the Company in connection with a Business Combination or affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. The Company has until December 31, 2022 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per -share In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.00 per Public Share, except as to any claims by a third party who executed a valid and enforceable agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Insiders will not be responsible to the extent of any liability for such third -party On April 14, 2021, the Company held a stockholder meeting to extend the date by which the Company has to consummate a business combination from April 16, 2021 to September 30, 2021. As part of the meeting, stockholders redeemed 2,558,740 On September 28, 2021, the Company held a stockholder meeting to further extend the date by which the Company has to consummate a business combination from September 30, 2021 to December 31, 2021. As part of the meeting, stockholders redeemed 2,284,305 On December 27, 2021, the Company held a stockholder meeting to further extend the date by which the Company has to consummate a business combination from December 31, 2021 to March 31, 2022. As part of the meeting, stockholders redeemed 3,099,310 On March 29, 2022, the Company held a stockholder meeting to further extend the date by which the Company has to consummate a business combination from March 31, 2022 to June 30, 2022. As part of the meeting, stockholders redeemed 6,650,144 -interest On June 21, 2022, the Company held a stockholder meeting to further extend the date by which the Company has to consummate a business combination from June 30, 2022 to December 31, 2022. As part of the meeting, stockholders redeemed 39,400 -interest Going Concern Consideration As of June 30, 2022, the Company had $61,865 in its operating bank accounts and working capital deficit of $300,774, excluding the related party promissory note of $2,699,020, and Delaware franchise taxes of $22,284. The Company will need to raise additional capital through loans or additional investments from our initial stockholders, officers or directors. If the Company is unable to raise additional capital, obtain approval for an extension of the deadline or complete a Business Combination by December 31, 2022, then the Company will cease all operations except for the purpose of liquidating. The Company has until December 31, 2022 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by the specified period. If a Business Combination is not consummated by December 31, 2022, there will be a mandatory liquidation and subsequent dissolution. The liquidity condition and date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern one year from the date that these financial statements are issued. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Risks and Uncertainties Management continues to evaluate the impact of the COVID -19 In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements. Nasdaq Notification On January 5, 2021, the Company received a notice from the staff of the Listing Qualifications Department of Nasdaq (the “Staff”) stating that the Company was no longer in compliance with Nasdaq Listing Rule 5620(a) for continued listing due to its failure to hold an annual meeting of stockholders within twelve months of the end of the Company’s fiscal year ended December 31, 2019. In accordance with Nasdaq Listing Rule 5810(c)(2)(G), the Company submitted a plan to regain compliance on February 17, 2021. Nasdaq accepted our plan and granted us an extension through June 29, 2021 to hold an annual meeting. The Company held the required annual meeting on April 14, 2021.	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Tuscan Holdings Corp. II (the “ Company Business Combination The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of December 31, 2021, the Company had not commenced any operations. All activity through December 31, 2021 relates to the Company’s formation, its initial public offering (“ Initial Public Offering -operating The registration statement for the Company’s Initial Public Offering was declared effective on July 11, 2019. On July 16, 2019, the Company consummated the Initial Public Offering of 15,000,000 units (the “ Units Public Shares Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 215,000 units (the “ Private Units Private Warrants Private Securities sponsor EarlyBirdCapital Following the closing of the Initial Public Offering on July 16, 2019, an amount of $150,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Securities was placed in a trust account (the “ Trust Account Investment Company Act -ended -7 On July 18, 2019, the underwriters exercised their over -allotment -allotment Transaction costs amounted to $3,954,190, consisting of $3,450,000 of underwriting fees and $504,190 of other offering costs, of which $3,945,961 were charged to equity and $8,229 was expensed through the statements of operations. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Securities, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post -transaction acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account ($10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income tax obligations and up to $250,000 per 12 -month The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “ Amended and Restated Certificate of Incorporation SEC The sponsor and EarlyBirdCapital (and its designee) have agreed (a) to waive their redemption rights with respect to their Founder Shares, Private Shares and Public Shares held by them in connection with the completion of a Business Combination, (b) to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares, Representative Shares and Private Shares if the Company fails to consummate a Business Combination, and (c) not to propose an amendment to the Amended and Restated Certificate of Incorporation that would affect a public stockholders’ ability to convert or sell their shares to the Company in connection with a Business Combination or affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. The Company has until June 30, 2022 (see Note 11) to consummate a Business Combination (the “ Combination Period -share under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. In order to protect the amounts held in the Trust Account, the sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.00 per Public Share, except as to any claims by a third party who executed a valid and enforceable agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “ Securities Act -party On April 14, 2021, the Company held a stockholder meeting to extend the date by which the Company has to consummate a business combination from April 16, 2021 to September 30, 2021. As part of the meeting, stockholders redeemed 2,558,740 On September 28, 2021, the Company held a stockholder meeting to further extend the date by which the Company has to consummate a business combination from September 30, 2021 to December 31, 2021. As part of the meeting, stockholders redeemed 2,284,305 Contribution On December 27, 2021, the Company held a stockholder meeting to further extend the date by which the Company has to consummate a business combination from December 31, 2021 to March 31, 2022. As part of the meeting, stockholders redeemed 3,099,310 Going Concern Consideration As of December 31, 2021, the Company had $267,965 in its operating bank accounts and working capital of $59,629, excluding the redemption liability of $31,596,178, related party promissory note of 2,171,460, and Delaware franchise taxes of $406,311. The Company will need to raise additional capital through loans or additional investments from our initial stockholders, officers or directors. If the Company is unable to raise additional capital, obtain approval for an extension of the deadline or complete a Business Combination by June 30, 2022, then the Company will cease all operations except for the purpose of liquidating. The Company has until June 30, 2022 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by the specified period. If a Business Combination is not consummated by June 30, 2022, there will be a mandatory liquidation and subsequent dissolution. The liquidity condition and date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern one year from the date that these financial statements are issued. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Risks and Uncertainties Management continues to evaluate the impact of the COVID -19 Nasdaq Notification On January 5, 2021, the Company received a notice from the staff of the Listing Qualifications Department of Nasdaq (the “ Staff

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10 -Q -X The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10 -K Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes -Oxley Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non -emerging Use of Estimates The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short -term Cash and Marketable Securities Held in Trust Account At June 30, 2022 and December 31, 2021, substantially all of the assets held in the Trust Account were held in U.S Treasury Bills or as cash. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. Warrant Liabilities The Company accounts for warrants in accordance with the guidance contained in ASC 815 -40 -measurement Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit. At June 30, 2022, the Common stock reflected in the condensed balance sheets are reconciled in the following table: Common stock subject to possible redemption as of December 31, 2021 95,412,038 Less: Public Shares Redeemed (68,389,195 ) Add: Remeasurement of carrying value to redemption value 287,769 Common stock subject to possible redemption as of June 30, 2022 $ 27,310,612 Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of June 30, 2022 and December 31, 2021, the Company’s deferred tax asset had a full valuation allowance recorded against it. The effective tax rate differs from the statutory tax rate of 21% for the three months and six months ended June 30, 2022 and 2021, due to changes in fair value in warrant liability, expenses related to the proposed Business Combination, and the valuation allowance on the deferred tax assets. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more -likely-than-not The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Income (Loss) Per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common stock is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. The Company calculates earnings per share by allocating net income to a single class of common stock. Accretion associated with the redeemable common stock is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 11,118,750 Class A common stock in the aggregate. As of June 30, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income (loss) per common stock is the same as basic net income (loss) per common stock for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per common stock (in dollars, except per share amounts): Three Months Ended Six Months Ended 2022 2021 2022 2021 Basic and diluted net income(loss) per common stock Numerator: Allocation of net income (loss) $ 578,625 $ (405,234 ) $ 30,725 $ 549,460 Denominator: Basic and diluted weighted average shares outstanding 7,391,537 19,428,760 10,626,479 20,403,518 Basic and diluted net income (loss) per common stock $ 0.08 $ (0.06 ) $ 0.00 $ 0.08 Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximate the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short -term Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re -valued -current -cash Recent Accounting Standards Management does not believe there are any recently issued, but not yet effective, accounting standards, if currently adopted, that would have a material effect on the Company’s condensed financial statements.	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“ GAAP Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “ JOBS Act -Oxley Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non -emerging Use of Estimates The preparation of the financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short -term Cash and Marketable Securities Held in Trust Account At December 31, 2021 and 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills or as cash. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. Warrant Liabilities The Company accounts for warrants in accordance with the guidance contained in ASC 815 -40 -measurement Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ ASC The Company recognizes the initial measurement of redemption value immediately as it occurs and remeasures or adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid -in At December 31, 2021 and December 31, 2020, the Common stock subject to possible redemption reflected in the balance sheets are reconciled in the following table: Common stock subject to possible redemption as of December 30, 2019 173,690,176 Plus: Remeasurement adjustment to amount subject to redemption 591,129 Common stock subject to possible redemption as of December 30, 2020 174,281,305 Less: Public Shares Redeemed (80,482,623 ) Add: Remeasurement adjustment to amount subject to redemption 1,613,356 Common stock subject to possible redemption as of December 31, 2021 $ 95,412,038 Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2021 and 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. On March 27, 2020, President Trump signed the Coronavirus Aid, Relief, and Economic Security “CARES” Act into law. The CARES Act includes several significant business tax provisions that, among other things, would eliminate the taxable income limit for certain net operating losses (“ NOLs Net Income (Loss) Per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common stock is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. The Company calculates earnings per share by allocating net income to a single class of common stock. Accretion associated with the redeemable common stock is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 11,118,750 Class A common stock in the aggregate. As of December 31, 2021 and 2020, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income (loss) per common stock is the same as basic net income (loss) per common stock for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per common stock (in dollars, except per share amounts: Year Ended December 31, 2021 2020 Basic and diluted net income (loss) per common stock Numerator: Net income (loss) $ 1,776,014 $ (843,428 ) Denominator: Basic and diluted weighted average shares outstanding 19,550,323 21,987,500 Basic and diluted net income (loss) per share of common stock $ 0.09 $ (0.04 ) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short -term Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re -valued -current -cash Adopted Accounting Standards In August 2020, the FASB issued ASU No. 2020 -06 -20 -40 ASU 2020 -06 -06 -06 -06 -06 Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Related Party Transactions

Related Party Transactions	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 3. RELATED PARTY TRANSACTIONS Founder Shares The Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until, with respect to 50% of the Founder Shares, the earlier of one year after the consummation of a Business Combination and the date on which the closing price of the common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 -trading Other Receivable — Related Party During the year ended December 31, 2021, the Company paid expenses on behalf of an affiliate that were mainly settled during the year ended December 31, 2021. No amount was due or outstanding from this affiliate as of June 30, 2022 and December 31, 2021. Administrative Support Agreement The Company entered into an agreement whereby, commencing on July 11, 2019, through the earlier of the Company’s consummation of a Business Combination and its liquidation, the Company will pay an affiliate of the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support. For the three and six months ended June 30, 2022 and 2021, the Company incurred $30,000 and $60,000, and paid $30,000 and $60,000 in fees for these services, respectively. Promissory Note — Related Party On September 28, 2021, as part of the extension meeting to extend the liquidation date to December 31, 2021, the Sponsor agreed that if the Extension Amendment Proposal was approved, it or its affiliates would lend to the Company $0.10 (such loan being referred to herein as the “Contribution”) for each public share that was not converted in connection with the stockholder vote to approve the proposal. Accordingly, the sponsor lent an aggregate of $1,240,695 to the Company. The Contribution was non -interest On December 27, 2021, as part of the extension meeting to extend the liquidation date to March 31, 2022, the Sponsor agreed that if the Extension Amendment Proposal was approved, it or its affiliates would lend to the Company $0.10 for each public share that was not converted in connection with the stockholder vote to approve the proposal. Accordingly, the sponsor lent an aggregate of $930,765 to the Company. The Contribution was non -interest On March 29, 2022, as part of the extension meeting to extend the liquidation date to June 30, 2022, the Sponsor agreed that if the Extension Amendment Proposal was approved, it or its affiliates would lend to the Company $0.10 for each public share that was not converted in connection with the stockholder vote to approve the proposal. Accordingly, the sponsor lent an aggregate of $265,750 to the Company. The Contribution is non -interest On June 21, 2022, as part of the extension meeting to extend the liquidation date to December 31, 2022, the Sponsor agreed that if the Extension Amendment Proposal was approved, it or its affiliates would lend to the Company $0.10 for each public share that was not converted in connection with the stockholder vote to approve the proposal. Accordingly, the sponsor lent an aggregate of $261,810 to the Company. The Contribution is non -interest Related Party Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Insiders, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $750,000 of such Working Capital Loans may be converted into units of the post Business Combination entity at a price of $10.00 per unit and up to $750,000 of such Working Capital Loans may be converted into warrants of the post Business Combination entity at a price of $1.00 per warrant. The units and warrants would be identical to the Private Units and Private Warrants, respectively. No working capital loans were issued or outstanding as of June 30, 2022 and December 31, 2021.	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares In March 2019, the sponsor purchased 3,593,750 Founder Shares stock dividend”), -allotment -share -allotment The sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until, with respect to 50% of the Founder Shares, the earlier of one year after the consummation of a Business Combination and the date on which the closing price of the common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 -trading Founder Shares, until the one year after the consummation of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company completes a liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Other Receivable — Related Party During the year ended December 31, 2021, we paid expenses on behalf of an affiliate that were mainly settled during the year ended December 31, 2021. An aggregate amount of $0 and $22,195 was due from this affiliate as of December 31, 2021 and 2020, respectively. Administrative Support Agreement The Company entered into an agreement whereby, commencing on July 11, 2019, through the earlier of the Company’s consummation of a Business Combination and its liquidation, the Company will pay an affiliate of the CEO a total of $10,000 per month for office space, utilities and secretarial and administrative support. For the year ended December 31, 2021 and 2020, the Company incurred and paid $120,000 in fees for these services. Promissory Note — Related Party In March 2019, the Company issued an unsecured promissory note to the Company’s Chief Executive Officer (the “ Promissory Note -interest On September 28, 2021, as part of the extension meeting to extend the liquidation date to December 31, 2021, the sponsor agreed that if the Extension Amendment Proposal was approved, it or its affiliates would lend to the Company $0.10 (such loan being referred to herein as the “ Contribution -interest On December 27, 2021, as part of the extension meeting to extend the liquidation date to March 31, 2022, the sponsor agreed that if the Extension Amendment Proposal was approved, it or its affiliates would lend to the Company $0.10 for each public share that was not converted in connection with the stockholder vote to approve the proposal. Accordingly, the sponsor lent an aggregate of $930,765 to the Company. The Contribution was non -interest Related Party Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Insiders, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“ Working Capital Loans”). may be converted into units of the post Business Combination entity at a price of $10.00 per unit and up to $750,000 of such Working Capital Loans may be converted into warrants of the post Business Combination entity at a price of $1.00 per warrant. The units and warrants would be identical to the Private Units and Private Warrants, respectively. No working capital loans were issued or outstanding as of December 31, 2021.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Disclosure Text Block Supplement [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 4. COMMITMENTS AND CONTINGENCIES Registration Rights Pursuant to a registration rights agreement entered into on July 11, 2019, the holders of the Founder Shares, Representative Shares, Private Securities, and any units and warrants that may be issued upon conversion of Working Capital Loans (and all underlying securities) will be entitled to registration rights. The holders of the majority of these securities are entitled to make up to two demands that the Company register such securities. The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three months prior to the date on which the Founder Shares are to be released from escrow. The holders of a majority of the Representative Shares, Private Securities or units and warrants issued in payment of Working Capital Loans made to the Company (or underlying securities) can elect to exercise these registration rights at any time commencing after the Company consummates a Business Combination. Notwithstanding anything to the contrary, EarlyBirdCapital may only make a demand on one occasion and only during the five -year -back -back -year Business Combination Marketing Agreement The Company has engaged EarlyBirdCapital as an advisor in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with a Business Combination, assist the Company in obtaining shareholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination. The Company will pay EarlyBirdCapital a cash fee for such services upon the consummation of a Business Combination in an amount equal to $6,037,500 (exclusive of any applicable finders’ fees which might become payable); provided that up to 30% of the fee may be allocated at the Company’s sole discretion to other FINRA members that assist the Company in identifying and consummating a Business Combination. Extension Meetings On April 24, 2021, the Company held a stockholder meeting to extend the date by which the Company has to consummate a business combination from April 16, 2021 to September 30, 2021. As part of the meeting, stockholders redeemed 2,558,740 On September 28, 2021, the Company held a stockholder meeting to further extend the date by which the Company has to consummate a business combination from September 30, 2021 to December 31, 2021. As part of the meeting, stockholders redeemed 2,284,305 On September 28, 2021, as part of the extension meeting to extend the liquidation date to December 31, 2021, the Sponsor agreed that if the Extension Amendment Proposal was approved, it or its affiliates would lend to the Company $0.10 for each public share that was not converted in connection with the stockholder vote to approve the proposal. Accordingly, the sponsor lent an aggregate of $1,240,695 to the Company. The Contribution was non -interest On December 27, 2021, as part of the extension meeting to extend the liquidation date to March 31, 2022, the Sponsor agreed that if the Extension Amendment Proposal was approved, it or its affiliates would lend to the Company $0.10 for each public share that was not converted in connection with the stockholder vote to approve the proposal. Accordingly, the sponsor lent an aggregate of $930,765 to the Company. The Contribution was non -interest On March 29, 2022, the Company held a stockholder meeting to further extend the date by which the Company has to consummate a business combination from March 31, 2022 to June 30, 2022. As part of the meeting, stockholders redeemed 6,650,144 -interest On June 21, 2022, the Company held a stockholder meeting to further extend the date by which the Company has to consummate a business combination from June 30, 2022 to December 31, 2022. As part of the meeting, stockholders redeemed 39,400 -interest Redemption Liability On December 27, 2021, as part of the extension meeting to extend the liquidation date to March 31, 2022, where stockholders redeemed 3,099,310 Business Combination Agreement On May 17, 2022, Tuscan Holdings Corp. II (“Tuscan”), Surf Air Global Limited (the “Company”), Surf Air Mobility Inc., a wholly -owned -owned -owned Pursuant to the Merger Agreement, upon the closing of the transactions contemplated by the Merger Agreement (the “Transactions”), Merger Sub I will merge with and into Tuscan, with Tuscan surviving, and, simultaneously therewith, Merger Sub II will merge with and into the Company, with the Company surviving (collectively, the “Mergers”). The Merger Agreement contemplates a related business combination transaction pursuant to which on the closing date a wholly -owned -owned	NOTE 6. COMMITMENTS Registration Rights Pursuant to a registration rights agreement entered into on July 11, 2019, the holders of the Founder Shares, Representative Shares, Private Securities, and any units and warrants that may be issued upon conversion of Working Capital Loans (and all underlying securities) will be entitled to registration rights. The holders of the majority of these securities are entitled to make up to two demands that the Company register such securities. The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three months prior to the date on which the Founder Shares are to be released from escrow. The holders of a majority of the Representative Shares, Private Securities or units and warrants issued in payment of Working Capital Loans made to the Company (or underlying securities) can elect to exercise these registration rights at any time commencing after the Company consummates a Business Combination. Notwithstanding anything to the contrary, EarlyBirdCapital may only make a demand on one occasion and only during the five -year -back -back -year Business Combination Marketing Agreement The Company has engaged EarlyBirdCapital as an advisor in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with a Business Combination, assist the Company in obtaining shareholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination. The Company will pay EarlyBirdCapital a cash fee for such services upon the consummation of a Business Combination in an amount equal to $6,037,500 (exclusive of any applicable finders’ fees which might become payable); provided that up to 30% of the fee may be allocated at the Company’s sole discretion to other FINRA members that assist the Company in identifying and consummating a Business Combination. On April 24, 2021, the Company held a stockholder meeting to extend the date by which the Company has to consummate a business combination from April 16, 2021 to September 30, 2021. As part of the meeting, stockholders redeemed 2,558,740 On September 28, 2021, the Company held a stockholder meeting to further extend the date by which the Company has to consummate a business combination from September 30, 2021 to December 31, 2021. As part of the meeting, stockholders redeemed 2,284,305 On September 28, 2021, as part of the extension meeting to extend the liquidation date to December 31, 2021, the sponsor agreed that if the Extension Amendment Proposal was approved, it or its affiliates would lend to the Company $0.10 for each public share that was not converted in connection with the stockholder vote to approve the proposal. Accordingly, the sponsor lent an aggregate of $1,240,695 to the Company. The Contribution was non -interest On December 27, 2021, as part of the extension meeting to extend the liquidation date to March 31, 2022, the sponsor agreed that if the Extension Amendment Proposal was approved, it or its affiliates would lend to the Company $0.10 for each public share that was not converted in connection with the stockholder vote to approve the proposal. Accordingly, the sponsor lent an aggregate of $930,765 to the Company. The Contribution was non -interest Redemption Liability On December 27, 2021, as part of the extension meeting to extend the liquidation date to March 31, 2022, where stockholders redeemed 3,099,310

Stockholders_ Deficit

Stockholders’ Deficit	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
STOCKHOLDERS’ DEFICIT	NOTE 5. STOCKHOLDERS’ DEFICIT Preferred Stock — The Company is authorized to issue 1,000,000 no Common Stock — The Company is authorized to issue 50,000,000 Representative Shares On March 5, 2019, the Company issued to the designees of EarlyBirdCapital 187,500	NOTE 7. STOCKHOLDERS’ DEFICIT Preferred Stock — no Common Stock

Warrants

Warrants	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Warrants Abstract
WARRANTS	NOTE 6. WARRANTS Warrants — The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the public warrants is not effective within a specified period following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five Once the warrants become exercisable, the Company may redeem the Public Warrants: • • • • -trading • If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The Private Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Warrants and the shares of common stock issuable upon the exercise of the Private Warrants will not be transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and be non -redeemable The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if (x) the Company issues additional shares of common stock or equity -linked -linked The Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock -up	NOTE 8. WARRANT LIABILITIES Warrants five • • • • • -trading • If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. Under ASC 810 -40 The Private Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Warrants and the shares of common stock issuable upon the exercise of the Private Warrants will not be transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and be non -redeemable -40 The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if (x) the Company issues additional shares of common stock or equity -linked Market Value -linked Representative Shares On March 5, 2019, the Company issued to the designees of EarlyBirdCapital 187,500 Representative Shares The Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock -up

Fair Value Measurements

Fair Value Measurements	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 7. FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re -measured -financial -measured The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. At June 30, 2022, the Company had a total of $ 27,332,896 invested in marketable securities. At December 31, 2021, the Company had a total of $126,483,655 invested in marketable securities and a cash balance of $930,872 that was deposited into the trust account for the extension contribution described in Note 3. The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2022 and December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level June 30, December 31, 2021 Assets: Marketable securities held in Trust Account 1 $ 27,332,896 $ 126,483,655 Liabilities: Warrant Liability – Private Placement Warrants 3 $ 423,937 $ 1,054,856 The Warrants were accounted for as liabilities in accordance with ASC 815 -40 The Private Warrants were valued using a binomial lattice simulation model, which is considered to be a Level 3 fair value measurement. The binomial lattice model’s primary unobservable input utilized in determining the fair value of the Private Warrants is the expected volatility of the common stock. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank -check -days The key inputs into the Binomial Lattice Model for the Private Placement Warrants were as follows: June 30, December 31, Risk-free interest rate 2.97 % 1.27 % Time to maturity (years) 5.5 5.21 Dividend yield 0.00 % 0.00 % Expected volatility — % 7.0 % Probability of Acquisition 30.0 % 100.0 % Exercise price $ 11.50 $ 11.50 Unit Price $ 11.34 $ 10.21 As of June 30, 2022 and December 31, 2021, the aggregate fair values of the Private Placement Warrants were $0.42 million and $1.05 million, respectively. The following table presents the changes in the fair value of warrant liabilities for the three and six months ended June 30, 2022: Private Fair value as of December 31, 2021 $ 1,054,856 Change in fair value 291,769 Fair value as of March 31, 2022 1,346,625 Change in fair value (922,688 ) Fair value as of June 30, 2022 423,937 The following table presents the changes in the fair value of warrant liabilities for the three and six months ended June 30, 2021: Private Fair value as of December 31, 2020 $ 3,865,313 Change in fair value (1,147,125 ) Fair value as of March 31, 2021 2,718,188 Change in fair value 172,068 Fair value as of June 30, 2021 2,890,256 There were no transfers in or out of Level 3 from other levels in the fair value hierarchy during the three and six months ended June 30, 2022 and 2021.	NOTE 10. FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re -measured -financial -measured The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The Company had a total of $126,483,655 invested in marketable securities and a cash balance of $930,765 that was deposited into the trust account for the extension contribution described in Note 5. The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2021 and 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level December 31, 2021 December 31, 2020 Assets: Marketable securities held in Trust Account 1 $ 126,483,655 $ 174,550,466 Liabilities: Warrant liability – Private Placement Warrants 3 $ 1,054,856 $ 3,865,313 The Private Warrants were accounted for as liabilities in accordance with ASC 815 -40 The Private Warrants were initially valued using a binomial lattice, which is considered to be a Level 3 fair value measurement. The binomial lattice model’s primary unobservable input utilized in determining the fair value of the Private Warrants is the expected volatility of the common stock. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank -check -days As of July 16, 2019, the estimated fair value of the Private Warrants was determined using a Binomial Lattice Model and based upon the following significant inputs: Input July 16, Risk-free interest rate 1.92 % Time to maturity (years) 6.0 Dividend yield 0.0 % Expected volatility 15.3 % Probability of Acquisition 80.0 % Exercise price $ 11.50 Unit Price $ 10.00 Subsequent Measurement The Warrants are measured at fair value on a recurring basis. The subsequent measurement of the Private Placement Warrants was calculated using a Binomial Lattice Model which is considered a Level 3 measurement. The key inputs into the Binomial Lattice Model for the Private Placement Warrants were as follows at December 31, 2021 and 2020, respectively: December 31, 2021 December 31, 2020 Risk-free interest rate 1.27 % 0.40 % Time to maturity (years) 5.21 5.29 Dividend yield 0.00 % 0.0 % Expected volatility 7.0 % 23.1 % Probability of Acquisition 100.0 % 70.0 % Exercise price $ 11.50 $ 11.50 Unit Price $ 10.21 $ 11.01 As of December 31, 2021 and 2020, the aggregate fair values of the Private Placement Warrants were $1.05 million and $3.87 million, respectively. The following table presents the changes in the fair value of warrant liabilities: Private Fair value as of December 31, 2020 $ 3,865,313 Change in fair value (2,810,457 ) Fair value as of December 31, 2021 1,054,856 Level 3 financial liabilities consist of the Private Placement Warrant liability for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. The Company had no transfers out of Level 3.

Subsequent Events

Subsequent Events	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 8. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements. On September	NOTE 11. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. On March 29, 2022, the Company held a stockholder meeting to further extend the date by which the Company has to consummate a business combination from March 31, 2022 to June 30, 2022. As part of the meeting, stockholders redeemed 6,650,144 -interest

Public Offering

Public Offering	12 Months Ended
	Dec. 31, 2021
Initial Public Offering Disclosure Abstract
PUBLIC OFFERING	NOTE 3. PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 15,000,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of common stock and one -half Public Warrant -allotment

Private Placement

Private Placement	12 Months Ended
	Dec. 31, 2021
Private Placement [Abstract]
PRIVATE PLACEMENT	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the sponsor and EarlyBirdCapital and its designee purchased an aggregate of 215,000 Private Units at a price of $10.00 per Private Unit, and 2,150,000 Private Warrants at a price of $1.00 per Private Warrant for an aggregate purchase price of $4,300,000. The sponsor purchased 179,638 Private Units and EarlyBirdCapital and its designee purchased an aggregate of 35,362 Private Units. In addition, the sponsor purchased 1,796,380 Private Warrants and EarlyBirdCapital and its designee purchased an aggregate of 353,620 Private Warrants. On July 19, 2019, in connection with the underwriters’ exercise of the over -allotment -allotment Private Share -half Private Warrant

Income Tax

Income Tax	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
INCOME TAX	NOTE 9. INCOME TAX The Company’s net deferred tax assets/(liabilities) are as follows: December 31, 2021 2020 Deferred tax liability Net operating loss carryforward $ 202,195 $ — Unrealized gain on marketable securities — (1,282 ) Total deferred tax liability 202,195 (1,282 ) Valuation Allowance (202,195 ) — Deferred tax liability $ — $ (1,282 ) The income tax provision consists of the following: As of 2021 2020 Federal Current $ — $ 166,676 Deferred (202,195 ) (6,400 ) State and Local Current — — Deferred — — Change in valuation allowance 202,195 — Income tax provision $ — $ 160,276 As of December 31, 2021 and 2020, the Company has $962,832 and $0 U.S. federal net operating loss carryovers, respectively, available to offset future taxable income, which can be carried forward indefinitely. In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the years ended December 31, 2021 and 2020, the change in the valuation allowance was $202,195 and $0, respectively. A reconciliation of the federal income tax rate to the Company’s effective tax rate is as follows: December 31, December 31, Statutory federal income tax rate 21.0 % 21.0 % Change in fair value of warrant liabilities (33.0 )% (44.5 )% Interest and Penalties 1.0 % 0.0 % Valuation allowance 11.0 % 0.0 % Income tax provision 0.0 % (23.5 )% The Company files income tax returns in the U.S. federal jurisdiction and New York and is subject to examination by the various taxing authorities. The Company’s tax returns since inception remain open to examination by the taxing authorities. The Company considers New York to be a significant state tax jurisdiction.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10 -Q -X The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10 -K	Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“ GAAP
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes -Oxley Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non -emerging	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “ JOBS Act -Oxley Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non -emerging
Use of Estimates	Use of Estimates The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates.	Use of Estimates The preparation of the financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short -term	Cash and Cash Equivalents The Company considers all short -term
Cash and Marketable Securities Held in Trust Account	Cash and Marketable Securities Held in Trust Account At June 30, 2022 and December 31, 2021, substantially all of the assets held in the Trust Account were held in U.S Treasury Bills or as cash. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.	Cash and Marketable Securities Held in Trust Account At December 31, 2021 and 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills or as cash. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.
Warrant Liabilities	Warrant Liabilities The Company accounts for warrants in accordance with the guidance contained in ASC 815 -40 -measurement	Warrant Liabilities The Company accounts for warrants in accordance with the guidance contained in ASC 815 -40 -measurement
Common Stock Subject to Possible Redemption	Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit. At June 30, 2022, the Common stock reflected in the condensed balance sheets are reconciled in the following table: Common stock subject to possible redemption as of December 31, 2021 95,412,038 Less: Public Shares Redeemed (68,389,195 ) Add: Remeasurement of carrying value to redemption value 287,769 Common stock subject to possible redemption as of June 30, 2022 $ 27,310,612	Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ ASC The Company recognizes the initial measurement of redemption value immediately as it occurs and remeasures or adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid -in At December 31, 2021 and December 31, 2020, the Common stock subject to possible redemption reflected in the balance sheets are reconciled in the following table: Common stock subject to possible redemption as of December 30, 2019 173,690,176 Plus: Remeasurement adjustment to amount subject to redemption 591,129 Common stock subject to possible redemption as of December 30, 2020 174,281,305 Less: Public Shares Redeemed (80,482,623 ) Add: Remeasurement adjustment to amount subject to redemption 1,613,356 Common stock subject to possible redemption as of December 31, 2021 $ 95,412,038
Income Taxes	Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of June 30, 2022 and December 31, 2021, the Company’s deferred tax asset had a full valuation allowance recorded against it. The effective tax rate differs from the statutory tax rate of 21% for the three months and six months ended June 30, 2022 and 2021, due to changes in fair value in warrant liability, expenses related to the proposed Business Combination, and the valuation allowance on the deferred tax assets. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more -likely-than-not The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.	Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2021 and 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. On March 27, 2020, President Trump signed the Coronavirus Aid, Relief, and Economic Security “CARES” Act into law. The CARES Act includes several significant business tax provisions that, among other things, would eliminate the taxable income limit for certain net operating losses (“ NOLs
Net Income (Loss) Per Common Share	Net Income (Loss) Per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common stock is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. The Company calculates earnings per share by allocating net income to a single class of common stock. Accretion associated with the redeemable common stock is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 11,118,750 Class A common stock in the aggregate. As of June 30, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income (loss) per common stock is the same as basic net income (loss) per common stock for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per common stock (in dollars, except per share amounts): Three Months Ended Six Months Ended 2022 2021 2022 2021 Basic and diluted net income(loss) per common stock Numerator: Allocation of net income (loss) $ 578,625 $ (405,234 ) $ 30,725 $ 549,460 Denominator: Basic and diluted weighted average shares outstanding 7,391,537 19,428,760 10,626,479 20,403,518 Basic and diluted net income (loss) per common stock $ 0.08 $ (0.06 ) $ 0.00 $ 0.08	Net Income (Loss) Per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common stock is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. The Company calculates earnings per share by allocating net income to a single class of common stock. Accretion associated with the redeemable common stock is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 11,118,750 Class A common stock in the aggregate. As of December 31, 2021 and 2020, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income (loss) per common stock is the same as basic net income (loss) per common stock for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per common stock (in dollars, except per share amounts: Year Ended December 31, 2021 2020 Basic and diluted net income (loss) per common stock Numerator: Net income (loss) $ 1,776,014 $ (843,428 ) Denominator: Basic and diluted weighted average shares outstanding 19,550,323 21,987,500 Basic and diluted net income (loss) per share of common stock $ 0.09 $ (0.04 )
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments -term	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short -term
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re -valued -current -cash	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re -valued -current -cash
Recent Accounting Standards	Recent Accounting Standards Management does not believe there are any recently issued, but not yet effective, accounting standards, if currently adopted, that would have a material effect on the Company’s condensed financial statements.	Adopted Accounting Standards In August 2020, the FASB issued ASU No. 2020 -06 -20 -40 ASU 2020 -06 -06 -06 -06 -06 Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Schedule of condensed balance sheets are reconciled	Common stock subject to possible redemption as of December 31, 2021 95,412,038 Less: Public Shares Redeemed (68,389,195 ) Add: Remeasurement of carrying value to redemption value 287,769 Common stock subject to possible redemption as of June 30, 2022 $ 27,310,612	Common stock subject to possible redemption as of December 30, 2019 173,690,176 Plus: Remeasurement adjustment to amount subject to redemption 591,129 Common stock subject to possible redemption as of December 30, 2020 174,281,305 Less: Public Shares Redeemed (80,482,623 ) Add: Remeasurement adjustment to amount subject to redemption 1,613,356 Common stock subject to possible redemption as of December 31, 2021 $ 95,412,038
Schedule of basic and diluted net income (loss) per common stock	Three Months Ended Six Months Ended 2022 2021 2022 2021 Basic and diluted net income(loss) per common stock Numerator: Allocation of net income (loss) $ 578,625 $ (405,234 ) $ 30,725 $ 549,460 Denominator: Basic and diluted weighted average shares outstanding 7,391,537 19,428,760 10,626,479 20,403,518 Basic and diluted net income (loss) per common stock $ 0.08 $ (0.06 ) $ 0.00 $ 0.08	Year Ended December 31, 2021 2020 Basic and diluted net income (loss) per common stock Numerator: Net income (loss) $ 1,776,014 $ (843,428 ) Denominator: Basic and diluted weighted average shares outstanding 19,550,323 21,987,500 Basic and diluted net income (loss) per share of common stock $ 0.09 $ (0.04 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Schedule of assets and liabilities that are measured at fair value on a recurring basis	Description Level June 30, December 31, 2021 Assets: Marketable securities held in Trust Account 1 $ 27,332,896 $ 126,483,655 Liabilities: Warrant Liability – Private Placement Warrants 3 $ 423,937 $ 1,054,856	Description Level December 31, 2021 December 31, 2020 Assets: Marketable securities held in Trust Account 1 $ 126,483,655 $ 174,550,466 Liabilities: Warrant liability – Private Placement Warrants 3 $ 1,054,856 $ 3,865,313
Schedule of estimated fair value of private placement warrants	June 30, December 31, Risk-free interest rate 2.97 % 1.27 % Time to maturity (years) 5.5 5.21 Dividend yield 0.00 % 0.00 % Expected volatility — % 7.0 % Probability of Acquisition 30.0 % 100.0 % Exercise price $ 11.50 $ 11.50 Unit Price $ 11.34 $ 10.21	Input July 16, Risk-free interest rate 1.92 % Time to maturity (years) 6.0 Dividend yield 0.0 % Expected volatility 15.3 % Probability of Acquisition 80.0 % Exercise price $ 11.50 Unit Price $ 10.00 December 31, 2021 December 31, 2020 Risk-free interest rate 1.27 % 0.40 % Time to maturity (years) 5.21 5.29 Dividend yield 0.00 % 0.0 % Expected volatility 7.0 % 23.1 % Probability of Acquisition 100.0 % 70.0 % Exercise price $ 11.50 $ 11.50 Unit Price $ 10.21 $ 11.01
Schedule of changes in the fair value of warrant liabilities	Private Fair value as of December 31, 2021 $ 1,054,856 Change in fair value 291,769 Fair value as of March 31, 2022 1,346,625 Change in fair value (922,688 ) Fair value as of June 30, 2022 423,937 Private Fair value as of December 31, 2020 $ 3,865,313 Change in fair value (1,147,125 ) Fair value as of March 31, 2021 2,718,188 Change in fair value 172,068 Fair value as of June 30, 2021 2,890,256	Private Fair value as of December 31, 2020 $ 3,865,313 Change in fair value (2,810,457 ) Fair value as of December 31, 2021 1,054,856

Income Tax (Tables)

Income Tax (Tables)	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Schedule of net deferred tax liability	December 31, 2021 2020 Deferred tax liability Net operating loss carryforward $ 202,195 $ — Unrealized gain on marketable securities — (1,282 ) Total deferred tax liability 202,195 (1,282 ) Valuation Allowance (202,195 ) — Deferred tax liability $ — $ (1,282 )
Schedule of income tax provision	As of 2021 2020 Federal Current $ — $ 166,676 Deferred (202,195 ) (6,400 ) State and Local Current — — Deferred — — Change in valuation allowance 202,195 — Income tax provision $ — $ 160,276
Schedule of reconciliation of federal income tax rate	December 31, December 31, Statutory federal income tax rate 21.0 % 21.0 % Change in fair value of warrant liabilities (33.0 )% (44.5 )% Interest and Penalties 1.0 % 0.0 % Valuation allowance 11.0 % 0.0 % Income tax provision 0.0 % (23.5 )%

Description of Organization a_2

Description of Organization and Business Operations (Details) - USD ($)		1 Months Ended							6 Months Ended	12 Months Ended
	Apr. 14, 2021	Jun. 28, 2022	Jun. 21, 2022	Mar. 29, 2022	Dec. 27, 2021	Sep. 28, 2021	Jul. 18, 2019	Jul. 16, 2019	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Description of Organization and Business Operations (Details) [Line Items]
Price per share (in Dollars per share)				$ 0.1
Issuance of units, description									Following the closing of the Initial Public Offering on July 16, 2019, an amount of $150,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Securities was placed in a trust account (the “Trust Account”) which were invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account, as described below.	Following the closing of the Initial Public Offering on July 16, 2019, an amount of $150,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Securities was placed in a trust account (the “Trust Account”) which were invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account, as described below.
Fair market value, percentage									80%	80%
Description of working capital requirements									The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account ($10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income tax obligations and up to $250,000 per 12-month period for working capital requirements).	The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account ($10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income tax obligations and up to $250,000 per 12-month period for working capital requirements).
Redeemed shares of common stock (in Shares)	2,558,740					2,284,305
Cash balance	$ 25,828,000					$ 23,059,000
Public share (in Dollars per share)				$ 0.1	$ 0.1	$ 0.1				$ 0.1
Aggregate amount			$ 261,810	$ 265,750		$ 1,240,695			$ 1,240,695	$ 0	$ 22,195
Stockholders redeemed shares (in Shares)			39,400	6,650,144	3,099,310
Aggregate cash balance			$ 407,192	$ 67,982,003	$ 31,596,178
Operating bank accounts									61,865	267,965
Working capital									300,774	59,629
Related party promissory note									2,699,020	2,171,460
Delaware franchise taxes									$ 22,284	406,311
Transaction costs										3,954,190
Underwriting fees										3,450,000
Other offering costs										504,190
Equity charges										3,945,961
Expenses through statement of operations										8,229
Aggregate cash balance					31,596,000
Redemption liability										$ 31,596,178
Initial Public Offering [Member]
Description of Organization and Business Operations (Details) [Line Items]
Issuance of common stock (in Shares)								15,000,000		215,000
Initial Public Offering [Member] | Common Stock [Member]
Description of Organization and Business Operations (Details) [Line Items]
Price per share (in Dollars per share)								$ 10
Gross proceeds								$ 150,000,000
Over-Allotment Option [Member]
Description of Organization and Business Operations (Details) [Line Items]
Issuance of units, description							On July 18, 2019, the underwriters exercised their over-allotment option in full, resulting in an additional 2,250,000 Units issued on July 19, 2019 for $22,500,000, less the underwriters’ discount of $450,000. In connection with the underwriters’ exercise of their over-allotment option, the Company also consummated the sale of an additional 22,500 Private Units at $10.00 per Private Unit and the sale of an additional 225,000 Private Warrants at $1.00 per Private Warrant, generating total proceeds of $450,000. A total of $22,500,000 was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $172,500,000.
Public Shares [Member]
Description of Organization and Business Operations (Details) [Line Items]
Price per share (in Dollars per share)									$ 10	$ 10
Obligation to redeem percentage									100%	100%
Sponsor [Member]
Description of Organization and Business Operations (Details) [Line Items]
Public share (in Dollars per share)			$ 0.1
Aggregate amount		$ 261,810		$ 265,750	$ 930,765	$ 1,240,695				$ 930,765
Business Combination [Member]
Description of Organization and Business Operations (Details) [Line Items]
Ownership interest voting, percentage									50%	50%
Consummation of a business combination									$ 5,000,001	$ 5,000,001
Early Bird Capital [Member] | Sponsor [Member]
Description of Organization and Business Operations (Details) [Line Items]
Issuance of common stock (in Shares)										215,000
Price per share (in Dollars per share)									$ 10	$ 10
Gross proceeds									$ 4,300,000	$ 4,300,000
Private units (in Shares)									215,000
Sale of warrant (in Shares)									2,150,000	2,150,000
Sale of price per warrant (in Dollars per share)									$ 1	$ 1

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Summary of Significant Accounting Policies (Details) [Line Items]
Effective statutory tax rate	21%	21%	21%	21%
Federal depository insurance coverage (in Dollars)			$ 250,000		$ 250,000
Income tax rate					0%	(23.50%)
Technical correction rate					50%
Business Combination [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Income tax rate					30%
Class A Common Stock [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Purchase of warrants (in Shares)			11,118,750		11,118,750

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of condensed balance sheets are reconciled - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021	Dec. 30, 2020
Schedule Of Condensed Balance Sheets Are Reconciled Abstract
Common stock subject to possible redemption as of December 31, 2021	$ 95,412,038
Less:
Public Shares Redeemed	(68,389,195)	$ (80,482,623)
Add:
Remeasurement of carrying value to redemption value	287,769	1,613,356	$ 591,129
Common stock subject to possible redemption as of June 30, 2022	$ 27,310,612	$ 95,412,038

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted net income (loss) per common stock - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Numerator:
Allocation of net income (loss)	$ 578,625	$ (405,234)	$ 30,725	$ 549,460	$ 1,776,014	$ (843,428)
Denominator:
Basic weighted average shares outstanding	7,391,537	19,428,760	10,626,479	20,403,518	19,550,323	21,987,500
Basic net income (loss) per common stock	$ 0.08	$ (0.06)	$ 0	$ 0.08	$ 0.09	$ (0.04)

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted net income (loss) per common stock (Parentheticals) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Schedule Of Basic And Diluted Net Income Loss Per Common Stock Abstract
Diluted weighted average shares outstanding	7,391,537	19,428,760	10,626,479	20,403,518
Diluted net income (loss) per common stock	$ 0.08	$ (0.06)	$ 0	$ 0.08

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)

1 Months Ended

3 Months Ended

6 Months Ended

12 Months Ended

Jul. 11, 2019

Jun. 28, 2022

Jun. 21, 2022

Mar. 29, 2022

Dec. 27, 2021

Sep. 28, 2021

Mar. 31, 2019

Jun. 30, 2022

Jun. 30, 2021

Jun. 30, 2022

Jun. 30, 2021

Dec. 31, 2021

Dec. 31, 2020

Related Party Transactions (Details) [Line Items]

Fees incurred

$ 10,000

Service fees

$ 30,000

$ 30,000

$ 60,000

$ 60,000

$ 120,000

$ 120,000

Public share (in Dollars per share)

$ 0.1

$ 0.1

$ 0.1

$ 0.1

Aggregate amount

$ 261,810

$ 265,750

$ 1,240,695

$ 1,240,695

$ 0

22,195

Related party loans, description

The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $750,000 of such Working Capital Loans may be converted into units of the post Business Combination entity at a price of $10.00 per unit and up to $750,000 of such Working Capital Loans may be converted into warrants of the post Business Combination entity at a price of $1.00 per warrant. The units and warrants would be identical to the Private Units and Private Warrants, respectively.

The units and warrants would be identical to the Private Units and Private Warrants, respectively.

Repayment of borrowings amount

$ 149,000

Per share price (in Dollars per share)

$ 0.1

Amount outstanding

$ 2,171,460

Working capital loans

$ 750,000

Founder Shares [Member]

Related Party Transactions (Details) [Line Items]

Common stock dividend description

On July 11, 2019, the Company effected a stock dividend of 0.2 share for each share outstanding (the “stock dividend”), resulting in an aggregate of 4,312,500 Founder Shares outstanding. The Founder Shares included an aggregate of up to 562,500 shares subject to forfeiture by the sponsor to the extent that the underwriters’ over -allotment was not exercised in full or in part, so that the sponsor would collectively own 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the sponsor did not purchase any Public Shares in the Initial Public Offering and excluding the Private Units and Representative Shares) (see Note 8). All share and per-share amounts have been retroactively restated to reflect the stock dividend. In connection with the underwriters’ exercise of the over-allotment option in full, 562,500 Founder Shares are no longer subject to forfeiture.

The Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until, with respect to 50% of the Founder Shares, the earlier of one year after the consummation of a Business Combination and the date on which the closing price of the common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing after a Business Combination and, with respect to the remaining 50% of the Founder Shares, until the one year after the consummation of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company completes a liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.

Common stock shares purchased (in Shares)

3,593,750

Common stock aggregate price

$ 25,000

Business combination, description

The sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until, with respect to 50% of the Founder Shares, the earlier of one year after the consummation of a Business Combination and the date on which the closing price of the common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing after a Business Combination and, with respect to the remaining 50% of the

Business Combination [Member]

Related Party Transactions (Details) [Line Items]

Per share price (in Dollars per share)

$ 10

Working capital loans

$ 750,000

Warrants per share price (in Dollars per share)

$ 1

Chief Executive Officer [Member]

Related Party Transactions (Details) [Line Items]

Fees incurred

$ 10,000

Unsecured promissory note

$ 150,000

Sponsor [Member]

Related Party Transactions (Details) [Line Items]

Aggregate amount

$ 261,810

$ 265,750

$ 930,765

$ 1,240,695

$ 930,765

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	1 Months Ended					6 Months Ended	12 Months Ended
	Jun. 21, 2022	Mar. 29, 2022	Dec. 27, 2021	Sep. 28, 2021	Apr. 24, 2021	Jun. 30, 2022	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Business combination marketing agreement, description						The Company will pay EarlyBirdCapital a cash fee for such services upon the consummation of a Business Combination in an amount equal to $6,037,500 (exclusive of any applicable finders’ fees which might become payable); provided that up to 30% of the fee may be allocated at the Company’s sole discretion to other FINRA members that assist the Company in identifying and consummating a Business Combination.	The Company will pay EarlyBirdCapital a cash fee for such services upon the consummation of a Business Combination in an amount equal to $6,037,500 (exclusive of any applicable finders’ fees which might become payable); provided that up to 30% of the fee may be allocated at the Company’s sole discretion to other FINRA members that assist the Company in identifying and consummating a Business Combination.
Shares of common stock (in Shares)				2,284,305	2,558,740
Aggregate cash balance	$ 407,192	$ 67,982,003		$ 23,059,000	$ 25,828,000		$ 31,596,178
Public share (in Dollars per share)		$ 0.1	$ 0.1	$ 0.1
Aggregate amount	$ 261,810	$ 265,750	$ 930,765	$ 1,240,695
Stockholders redeemed (in Shares)	39,400	6,650,144	3,099,310
Total redemption liability							$ 31,596,178

Stockholders_ Deficit (Details)

Stockholders’ Deficit (Details) - $ / shares	Mar. 05, 2019	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Stockholders’ Deficit (Details) [Line Items]
Preferred stock, shares authorized		1,000,000	1,000,000	1,000,000
Preferred stock, par value (in Dollars per share)		$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock issued
Preferred stock outstanding
Common stock, shares authorized		50,000,000	50,000,000	50,000,000
Common stock, par value (in Dollars per share)		$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares issued		4,737,500	4,737,500	4,737,500
Common stock, shares outstanding		4,737,500	4,737,500	4,737,500
Common stock subject to possible redemptions		2,618,101	9,307,645	17,250,000
Shares of common stock	187,500
EarlyBirdCapital [Member]
Stockholders’ Deficit (Details) [Line Items]
Shares of common stock	187,500

Warrants (Details)

Warrants (Details) - $ / shares		6 Months Ended	12 Months Ended
	Mar. 05, 2019	Jun. 30, 2022	Dec. 31, 2021
Warrants (Details) [Line Items]
Warrant expiration term		5 years	5 years
Public warrants, description		Once the warrants become exercisable, the Company may redeem the Public Warrants:•        in whole and not in part;•        at a price of $0.01 per warrant;•        upon not less than 30 days’ prior written notice of redemption;•        if, and only if, the reported last sale price of the Company’s common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third business day prior to the notice of redemption to the warrant holders; and•        If, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants.	•        Once the warrants become exercisable, the Company may redeem the Public Warrants:•        in whole and not in part;•        at a price of $0.01 per warrant;•        upon not less than 30 days’ prior written notice of redemption;•        if, and only if, the reported last sale price of the Company’s common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third business day prior to the notice of redemption to the warrant holders; and•        If, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants.
Capital raising, description		In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of an initial Business Combination at an issue price or effective issue price of less than $9.50 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Sponsor, initial stockholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of an initial Business Combination on the date of the consummation of an initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummated an initial Business Combination (such price, the “Market Value”) is below $9.50 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at which the Company issues the additional shares of common stock or equity-linked securities.	In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of an initial Business Combination at an issue price or effective issue price of less than $9.50 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the sponsor, initial stockholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of an initial Business Combination on the date of the consummation of an initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummated an initial Business Combination (such price, the “Market Value”) is below $9.50 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at which the Company issues the additional shares of common stock or equity-linked securities.
Shares of common stock	187,500
Sponsor [Member]
Warrants (Details) [Line Items]
Founder shares issued	$ 1,094

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Marketable securities	$ 27,332,896	$ 126,483,655
Deposit amount		930,872
Private placement warrants	$ 420,000	1,050,000	$ 3,870,000
Deposited into the trust account		$ 930,765

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of assets and liabilities that are measured at fair value on a recurring basis - USD ($)	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Level 1 [Member]
Assets:
Marketable securities held in Trust Account	$ 27,332,896	$ 126,483,655	$ 174,550,466
Level 3 [Member]
Liabilities:
Warrant Liability – Private Placement Warrants	$ 423,937	$ 1,054,856	$ 3,865,313

Fair Value Measurements (Deta_3

Fair Value Measurements (Details) - Schedule of estimated fair value of private placement warrants - $ / shares	1 Months Ended	6 Months Ended	12 Months Ended
	Jul. 16, 2019	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Schedule Of Estimated Fair Value Of Private Placement Warrants Abstract
Risk-free interest rate	1.92%	2.97%	1.27%	0.40%
Time to maturity (years)	6 years	5 years 6 months	5 years 2 months 15 days	5 years 3 months 14 days
Dividend yield	0%	0%	0%	0%
Expected volatility	15.30%		7%	23.10%
Probability of Acquisition	80%	30%	100%	70%
Exercise price (in Dollars per share)	$ 11.5	$ 11.5	$ 11.5	$ 11.5
Unit Price (in Dollars per share)	$ 10	$ 11.34	$ 10.21	$ 11.01

Fair Value Measurements (Deta_4

Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities - USD ($)	3 Months Ended				12 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2021
Schedule Of Changes In The Fair Value Of Warrant Liabilities Abstract
Fair value beginning balance	$ 1,346,625	$ 1,054,856	$ 2,718,188	$ 3,865,313	$ 3,865,313
Change in fair value	(922,688)	291,769	172,068	(1,147,125)
Fair value ending balance	$ 423,937	$ 1,346,625	$ 2,890,256	$ 2,718,188	$ 1,054,856

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)		1 Months Ended
	Sep. 01, 2022	Mar. 29, 2022
Subsequent Events (Details) [Line Items]
Common stock share		6,650,144
Aggregate cash balance		67,982,000
Public shares (in Dollars per share)		$ 0.1
Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Loan aggregate amount (in Dollars)	$ 250,000
Interest payable, percentage	4%
Sponsor [Member]
Subsequent Events (Details) [Line Items]
Aggregate cash balance		265,750

Summary of Significant Accoun_7

Summary of Significant Accounting Policies (Details) - Schedule of condensed balance sheets are reconciled - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021	Dec. 30, 2020
Schedule Of Condensed Balance Sheets Are Reconciled Abstract
Common stock subject to possible redemption beginning	$ 95,412,038		$ 173,690,176
Plus:
Remeasurement adjustment to amount subject to redemption	287,769	$ 1,613,356	591,129
Common stock subject to possible redemption ending		95,412,038	$ 174,281,305
Less:
Public Shares Redeemed	$ (68,389,195)	$ (80,482,623)

Summary of Significant Accoun_8

Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted net income (loss) per common stock - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Numerator:
Net income (loss)	$ 578,625	$ (405,234)	$ 30,725	$ 549,460	$ 1,776,014	$ (843,428)
Denominator:
Basic weighted average shares outstanding	7,391,537	19,428,760	10,626,479	20,403,518	19,550,323	21,987,500
Basic net income (loss) per share of common stock	$ 0.08	$ (0.06)	$ 0	$ 0.08	$ 0.09	$ (0.04)

Summary of Significant Accoun_9

Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted net income (loss) per common stock (Parentheticals) - $ / shares	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Schedule Of Basic And Diluted Net Income Loss Per Common Stock Abstract
Diluted weighted average shares outstanding	7,391,537	19,428,760	10,626,479	20,403,518	19,550,323	21,987,500
Diluted net income (loss) per share of common stock	$ 0.08	$ (0.06)	$ 0	$ 0.08	$ 0.09	$ (0.04)

Public Offering (Details)

Public Offering (Details) - $ / shares	1 Months Ended	12 Months Ended
	Jul. 19, 2019	Dec. 31, 2021	Sep. 28, 2021
Public Offering (Details) [Line Items]
Price per unit			$ 0.1
Business combination, description		Each whole Public Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment (see Note 8).
IPO [Member]
Public Offering (Details) [Line Items]
Additional units sold		15,000,000
Price per unit		$ 10
Over-Allotment Option [Member]
Public Offering (Details) [Line Items]
Additional units sold	2,250,000
Price per unit	$ 10

Private Placement (Details)

Private Placement (Details) - USD ($)	1 Months Ended		12 Months Ended
	Jul. 19, 2019	Jul. 16, 2019	Dec. 31, 2021
IPO [Member]
Private Placement (Details) [Line Items]
Aggregate shares purchased		15,000,000	215,000
Price per share (in Dollars per share)			$ 10
Private Placement [Member]
Private Placement (Details) [Line Items]
Aggregate shares purchased			2,150,000
Private warrants price per share (in Dollars per share)			$ 1
Aggregate amount of purchased value (in Dollars)			$ 4,300,000
Private Placement [Member] | Common Stock [Member]
Private Placement (Details) [Line Items]
Exercise price, per share (in Dollars per share)			$ 11.5
Sponsor [Member]
Private Placement (Details) [Line Items]
Private placement, description	On July 19, 2019, in connection with the underwriters’ exercise of the over-allotment option in full, the sponsor and EarlyBirdCapital and its designee purchased an aggregate of 22,500 additional Private Units, of which 18,800 Private Units were purchased by the sponsor and 3,700 Private Units were purchased by EarlyBirdCapital and its designee, for an aggregate purchase price of $225,000.		The sponsor purchased 179,638 Private Units and EarlyBirdCapital and its designee purchased an aggregate of 35,362 Private Units. In addition, the sponsor purchased 1,796,380 Private Warrants and EarlyBirdCapital and its designee purchased an aggregate of 353,620 Private Warrants.
Aggregate shares purchased			188,000
Early Bird Capital [Member]
Private Placement (Details) [Line Items]
Aggregate amount of purchased value (in Dollars)			$ 225,000
Aggregate shares purchased			225,000
Purchase of private warrants			37,000

Income Tax (Details)

Income Tax (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
U.S. federal net operating loss carryovers	$ 962,832	$ 0
Valuation allowance	$ 202,195	$ 0

Income Tax (Details) - Schedule

Income Tax (Details) - Schedule of net deferred tax liability - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Deferred tax liability
Net operating loss carryforward	$ 202,195
Unrealized gain on marketable securities		(1,282)
Total deferred tax liability	202,195	(1,282)
Valuation Allowance	(202,195)
Deferred tax liability		$ (1,282)

Income Tax (Details) - Schedu_2

Income Tax (Details) - Schedule of income tax provision - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Federal
Current						$ 166,676
Deferred					(202,195)	(6,400)
State and Local
Current
Deferred
Change in valuation allowance					202,195
Income tax provision		$ 2,239		$ 2,239		$ 160,276

Income Tax (Details) - Schedu_3

Income Tax (Details) - Schedule of reconciliation of federal income tax rate	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule of Reconciliation of Federal Income Tax Rate [Abstract]
Statutory federal income tax rate	21%	21%
Change in fair value of warrant liabilities	(33.00%)	(44.50%)
Interest and Penalties	1%	0%
Valuation allowance	11%	0%
Income tax provision	0%	(23.50%)

Fair Value Measurements (Deta_5

Fair Value Measurements (Details) - Schedule of assets and liabilities - USD ($)	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Level 1 [Member]
Assets:
Marketable securities held in Trust Account	$ 27,332,896	$ 126,483,655	$ 174,550,466
Level 3 [Member]
Liabilities:
Warrant Liability – Private Placement Warrants	$ 423,937	$ 1,054,856	$ 3,865,313

Fair Value Measurements (Deta_6

Fair Value Measurements (Details) - Schedule of estimated fair value of private warrants - $ / shares	1 Months Ended	6 Months Ended	12 Months Ended
	Jul. 16, 2019	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Schedule Of Estimated Fair Value Of Private Warrants Abstract
Risk-free interest rate	1.92%	2.97%	1.27%	0.40%
Time to maturity (years)	6 years	5 years 6 months	5 years 2 months 15 days	5 years 3 months 14 days
Dividend yield	0%	0%	0%	0%
Expected volatility	15.30%		7%	23.10%
Probability of Acquisition	80%	30%	100%	70%
Exercise price (in Dollars per share)	$ 11.5	$ 11.5	$ 11.5	$ 11.5
Unit Price (in Dollars per share)	$ 10	$ 11.34	$ 10.21	$ 11.01

Fair Value Measurements (Deta_7

Fair Value Measurements (Details) - Schedule of changes in fair value of warrant liabilities - Private Placement Warrants [Member]	12 Months Ended
	Dec. 31, 2021 USD ($)
Fair Value Measurements (Details) - Schedule of changes in fair value of warrant liabilities [Line Items]
Fair value as of December 31, 2020	$ 3,865,313
Change in fair value	(2,810,457)
Fair value as of December 31, 2021	$ 1,054,856